Octagon Capital Advisors LP Omega Therapeutics, Inc. Transaction History

Octagon Capital Advisors LP

  • $414 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.01 - $7.19 $354,704 - $1.27 Million
-176,470 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$11.33 - $29.38 $2.2 Million - $5.69 Million
-193,809 Reduced 52.34%
176,470 $2 Million
Q3 2021

Nov 15, 2021
BUY
$16.0 - $22.51 $5.92 Million - $8.33 Million
370,279 New
370,279 $6.98 Million

Others Institutions Holding OMGA

# of Institutions
58
Shares Held
43.4M
Call Options Held
25.8K
Put Options Held
7K
View Full List

About Omega Therapeutics, Inc.

OMGA Quotes by TradingView
  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $37.8M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Octagon Capital Advisors LP Portfolio

Follow Octagon Capital Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Octagon Capital Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Octagon Capital Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email